SEARCH

SEARCH BY CITATION

References

  • Abbadie, C., Trafton, J., Liu, H., Mantyh, P.W. & Basbaum, A.I. (1997) Inflammation increases the distribution of dorsal horn neurons that internalize the neurokinin-1 receptor in response to noxious and non-noxious stimulation. J. Neurosci., 17, 80498060.
  • Adelson, D.W., Lao, L., Zhang, G., Kim, W. & Marvizón, J.C. (2009) Substance P release and neurokinin 1 receptor activation in the rat spinal cord increases with the firing frequency of C-fibers. Neuroscience, 161, 538553.
  • Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C.E., Brenner, G.J., Rubino, T., Michalski, C.W., Marsicano, G., Monory, K., Mackie, K., Marian, C., Batkai, S., Parolaro, D., Fischer, M.J., Reeh, P., Kunos, G., Kress, M., Lutz, B., Woolf, C.J. & Kuner, R. (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat. Neurosci., 10, 870879.
  • Aimone, L.D. & Yaksh, T.L. (1989) Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo. Peptides, 10, 11271131.
  • Aimone, L.D., Jones, S.L. & Gebhart, G.F. (1987) Stimulation-produced descending inhibition from the periaqueductal gray and nucleus raphe magnus in the rat: mediation by spinal monoamines but not opioids. Pain, 31, 123136.
  • Allen, B.J., Rogers, S.D., Ghilardi, J.R., Menning, P.M., Kuskowski, M.A., Basbaum, A.I., Simone, D.A. & Mantyh, P.W. (1997) Noxious cutaneous thermal stimuli induce a graded release of endogenous substance P in the spinal cord: imaging peptide action in vivo. J. Neurosci., 17, 59215927.
  • Anand, P., Whiteside, G., Fowler, C.J. & Hohmann, A.G. (2009) Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res. Rev., 60, 255266.
  • Ashton, J.C. & Milligan, E.D. (2008) Cannabinoids for the treatment of neuropathic pain: clinical evidence. Curr. Opin. Investig. Drugs, 9, 6575.
  • Beltramo, M., Bernardini, N., Bertorelli, R., Campanella, M., Nicolussi, E., Fredduzzi, S. & Reggiani, A. (2006) CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur. J. Neurosci., 23, 15301538.
  • Binzen, U., Greffrath, W., Hennessy, S., Bausen, M., Saaler-Reinhardt, S. & Treede, R.D. (2006) Co-expression of the voltage-gated potassium channel Kv1.4 with transient receptor potential channels (TRPV1 and TRPV2) and the cannabinoid receptor CB1 in rat dorsal root ganglion neurons. Neuroscience, 142, 527539.
  • Bridges, D., Rice, A.S., Egertova, M., Elphick, M.R., Winter, J. & Michael, G.J. (2003) Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience, 119, 803812.
  • Cannell, M.B., McMorland, A. & Soeller, C. (2006) Image Enhancement by Deconvolution. In Pawley, J.B. (ed), Handbook of Biological Confocal Microscopy. Springer, New York, NY, pp. 488500.
  • Chen, W. & Marvizon, J.C. (2009) Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by μ-opioid receptor internalization. Neuroscience, 161, 157172.
  • Chen, W., Song, B., Lao, L., Perez, O.A., Kim, W. & Marvizon, J.C.G. (2007) Comparing analgesia and μ-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition. Neuropharmacology, 53, 664667.
  • Cheppudira, B.P. (2006) Characterization of hind paw licking and lifting to noxious radiant heat in the rat with and without chronic inflammation. J. Neurosci. Methods, 155, 122125.
  • De Felipe, C., Herrero, J.F., O’Brien, J.A., Palmer, J.A., Doyle, C.A., Smith, A.J., Laird, J.M., Belmonte, C., Cervero, F. & Hunt, S.P. (1998) Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature, 392, 394397.
  • Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 19461949.
  • Farquhar-Smith, W.P., Egertova, M., Bradbury, E.J., McMahon, S.B., Rice, A.S. & Elphick, M.R. (2000) Cannabinoid CB(1) receptor expression in rat spinal cord. Mol. Cell. Neurosci., 15, 510521.
  • Gatley, S.J., Lan, R., Pyatt, B., Gifford, A.N., Volkow, N.D. & Makriyannis, A. (1997) Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci., 61, PL 191197.
  • Gatley, S.J., Lan, R., Volkow, N.D., Pappas, N., King, P., Wong, C.T., Gifford, A.N., Pyatt, B., Dewey, S.L. & Makriyannis, A. (1998) Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo. J. Neurochem., 70, 417423.
  • Gong, J.P., Onaivi, E.S., Ishiguro, H., Liu, Q.R., Tagliaferro, P.A., Brusco, A. & Uhl, G.R. (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res., 1071, 1023.
  • Grady, E.F., Baluk, P., Bohm, S., Gamp, P.D., Wong, H., Payan, D.G., Ansel, J., Portbury, A.L., Furness, J.B., McDonald, D.M. & Bunnett, N.W. (1996) Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract. J. Neurosci., 16, 69756986.
  • Hillard, C.J., Manna, S., Greenberg, M.J., DiCamelli, R., Ross, R.A., Stevenson, L.A., Murphy, V., Pertwee, R.G. & Campbell, W.B. (1999) Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J. Pharmacol. Exp. Ther., 289, 14271433.
  • Hohmann, A.G. & Herkenham, M. (1999) Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience, 90, 923931.
  • Hohmann, A.G. & Suplita, R.L. 2nd (2006) Endocannabinoid mechanisms of pain modulation. AAPS J., 8, E693E708.
  • Hohmann, A.G., Briley, E.M. & Herkenham, M. (1999) Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Res., 822, 1725.
  • Hohmann, A.G., Suplita, R.L., Bolton, N.M., Neely, M.H., Fegley, D., Mangieri, R., Krey, J.F., Walker, J.M., Holmes, P.V., Crystal, J.D., Duranti, A., Tontini, A., Mor, M., Tarzia, G. & Piomelli, D. (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature, 435, 11081112.
  • Holmes, T.J., Biggs, D. & Abu-Tarif, A. (2006) Blind Deconvolution. In Pawley, J.B. (ed), Handbook of Biological Confocal Microscopy. Springer, New York, NY, pp. 468487.
  • Honore, P., Menning, P.M., Rogers, S.D., Nichols, M.L., Basbaum, A.I., Besson, J.M. & Mantyh, P.W. (1999) Spinal cord substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states. J. Neurosci., 19, 76707678.
  • Hua, X. & Yaksh, T.L. (2009) Dorsal horn substance P and NK1 receptors: study of a model system in spinal nociceptive processing. In Malcangio, M. (ed), Synaptic Plasticity in Pain. Springer, London, pp. 109138.
  • Ibrahim, M.M., Porreca, F., Lai, J., Albrecht, P.J., Rice, F.L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T.W., Mata, H.P. & Malan, T.P. Jr (2005) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc. Natl Acad. Sci. USA, 102, 30933098.
  • Jensen, T.S. & Yaksh, T.L. (1984) Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Res., 321, 287297.
  • Jhaveri, M.D., Richardson, D. & Chapman, V. (2007a) Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. Br. J. Pharmacol., 152, 624632.
  • Jhaveri, M.D., Sagar, D.R., Elmes, S.J., Kendall, D.A. & Chapman, V. (2007b) Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain. Mol. Neurobiol., 36, 2635.
  • Johns, D.G., Behm, D.J., Walker, D.J., Ao, Z., Shapland, E.M., Daniels, D.A., Riddick, M., Dowell, S., Staton, P.C., Green, P., Shabon, U., Bao, W., Aiyar, N., Yue, T.L., Brown, A.J., Morrison, A.D. & Douglas, S.A. (2007) The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br. J. Pharmacol., 152, 825831.
  • Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M. & Watanabe, M. (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev., 89, 309380.
  • Karst, M., Salim, K., Burstein, S., Conrad, I., Hoy, L. & Schneider, U. (2003) Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA, 290, 17571762.
  • Khasabova, I.A., Harding-Rose, C., Simone, D.A. & Seybold, V.S. (2004) Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. J. Neurosci., 24, 17441753.
  • Kondo, I., Marvizon, J.C., Song, B., Salgado, F., Codeluppi, S., Hua, X.Y. & Yaksh, T.L. (2005) Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. J. Neurosci., 25, 36513660.
  • Laird, J.M., Olivar, T., Roza, C., De Felipe, C., Hunt, S.P. & Cervero, F. (2000) Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene. Neuroscience, 98, 345352.
  • Lan, R., Gatley, J., Lu, Q., Fan, P., Fernando, S.R., Volkow, N.D., Pertwee, R. & Makriyannis, A. (1999a) Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand. AAPS PharmSci., 1, E4.
  • Lan, R., Liu, Q., Fan, P., Lin, S., Fernando, S.R., McCallion, D., Pertwee, R. & Makriyannis, A. (1999b) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem., 42, 769776.
  • Lao, L. & Marvizon, J.C.G. (2005) GABA A receptor facilitation of neurokinin release from primary afferent terminals in the rat spinal cord. Neuroscience, 130, 10131027.
  • Lao, L., Song, B. & Marvizon, J.C.G. (2003) Neurokinin release produced by capsaicin acting on the central terminals and axons of primary afferents: relationship with NMDA and GABAB receptors. Neuroscience, 121, 667680.
  • Lao, L., Song, B., Chen, W. & Marvizon, J.C. (2008) Noxious mechanical stimulation evokes the segmental release of opioid peptides that induce μ-opioid receptor internalization in the presence of peptidase inhibitors. Brain Res., 1197, 8593.
  • Lauckner, J.E., Jensen, J.B., Chen, H.Y., Lu, H.C., Hille, B. & Mackie, K. (2008) GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc. Natl. Acad. Sci. U S A, 105, 26992704.
  • Lawson, S.N., Perry, M.J., Prabhakar, E. & McCarthy, P.W. (1993) Primary sensory neurones: neurofilament, neuropeptides and conduction velocity. Brain Res. Bull., 30, 239243.
  • Le Bars, D., Bourgoin, S., Clot, A.M., Hamon, M. & Cesselin, F. (1987) Noxious mechanical stimuli increase the release of Met-enkephalin-like material heterosegmentally in the rat spinal cord. Brain Res, 402, 188192.
  • Lever, I.J. & Malcangio, M. (2002) CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of substance P from the adult mouse spinal cord. Br. J. Pharmacol., 135, 2124.
  • Lever, I.J., Bradbury, E.J., Cunningham, J.R., Adelson, D.W., Jones, M.G., McMahon, S.B., Marvizon, J.C. & Malcangio, M. (2001) Brain-derived neurotrophic factor is released in the dorsal horn by distinctive patterns of afferent fiber stimulation. J. Neurosci., 21, 44694477.
  • Mackie, K. (2006) Cannabinoid receptors as therapeutic targets. Annu. Rev. Pharmacol. Toxicol., 46, 101122.
  • Malcangio, M. & Bowery, N.G. (1993) Gamma-aminobutyric acid B, but not gamma-aminobutyric acid A receptor activation, inhibits electrically evoked substance P-like immunoreactivity release from the rat spinal cord in vitro. J. Pharmacol. Exp. Ther., 266, 14901496.
  • Mantyh, P.W., DeMaster, E., Malhotra, A., Ghilardi, J.R., Rogers, S.D., Mantyh, C.R., Liu, H., Basbaum, A.I., Vigna, S.R. & Maggio, J.E. (1995) Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science, 268, 16291632.
  • Mantyh, P.W., Rogers, S.D., Honore, P., Allen, B.J., Ghilardi, J.R., Li, J., Daughters, R.S., Lappi, D.A., Wiley, R.G. & Simone, D.A. (1997) Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science, 278, 275279.
  • Marvizon, J.C., Martinez, V., Grady, E.F., Bunnett, N.W. & Mayer, E.A. (1997) Neurokinin 1 receptor internalization in spinal cord slices induced by dorsal root stimulation is mediated by NMDA receptors. J. Neurosci., 17, 81298136.
  • Marvizon, J.C., Grady, E.F., Stefani, E., Bunnett, N.W. & Mayer, E.A. (1999) Substance P release in the dorsal horn assessed by receptor internalization: NMDA receptors counteract a tonic inhibition by GABA(B) receptors. Eur. J. Neurosci., 11, 417426.
  • Marvizon, J.C., Wang, X., Matsuka, Y., Neubert, J.K. & Spigelman, I. (2003a) Relationship between capsaicin-evoked substance P release and neurokinin 1 receptor internalization in the rat spinal cord. Neuroscience, 118, 535545.
  • Marvizon, J.C.G., Wang, X., Lao, L. & Song, B. (2003b) Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord. Br. J. Pharmacol., 140, 13891398.
  • Morisset, V. & Urban, L. (2001) Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord. J. Neurophysiol., 86, 4048.
  • Motulsky, H. & Brown, R. (2006) Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinformatics, 7, 123.
  • Motulsky, H. & Christopoulos, A. (2003) Fitting Models to Biological Data using Linear and Nonlinear Regression. GraphPad Software, Inc., San Diego, CA.
  • Nazarian, A., Gu, G., Gracias, N.G., Wilkinson, K., Hua, X.Y., Vasko, M.R. & Yaksh, T.L. (2007) Spinal N-methyl-D-aspartate receptors and nociception-evoked release of primary afferent substance P. Neuroscience, 152, 119127.
  • Nyilas, R., Gregg, L.C., Mackie, K., Watanabe, M., Zimmer, A., Hohmann, A.G. & Katona, I. (2009) Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. Eur. J. Neurosci., 29, 19641978.
  • Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S. & Sugiura, T. (2007) Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem. Biophys. Res. Commun., 362, 928934.
  • Paronis, C.A. & Holtzman, S.G. (1991) Increased analgesic potency of mu agonists after continuous naloxone infusion in rats. J. Pharmacol. Exp. Ther., 259, 582589.
  • Pernia-Andrade, A.J., Kato, A., Witschi, R., Nyilas, R., Katona, I., Freund, T.F., Watanabe, M., Filitz, J., Koppert, W., Schuttler, J., Ji, G., Neugebauer, V., Marsicano, G., Lutz, B., Vanegas, H. & Zeilhofer, H.U. (2009) Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science, 325, 760764.
  • Pertwee, R.G. (1999) Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem., 6, 635664.
  • Pertwee, R.G. (2001) Cannabinoid receptors and pain. Prog. Neurobiol., 63, 569611.
  • Price, T.J., Patwardhan, A., Akopian, A.N., Hargreaves, K.M. & Flores, C.M. (2004) Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons. Br. J. Pharmacol., 142, 257266.
  • Raingo, J., Castiglioni, A.J. & Lipscombe, D. (2007) Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors. Nat. Neurosci., 10, 285292.
  • Richardson, J.D., Aanonsen, L. & Hargreaves, K.M. (1998) Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J. Neurosci., 18, 451457.
  • Riley, R.C., Trafton, J.A., Chi, S.I. & Basbaum, A.I. (2001) Presynaptic regulation of spinal cord tachykinin signaling via GABA(B) but not GABA(A) receptor activation. Neuroscience, 103, 725737.
  • Ross, R.A. (2009) The enigmatic pharmacology of GPR55. Trends Pharmacol. Sci., 30, 156163.
  • Ryberg, E., Larsson, N., Sjogren, S., Hjorth, S., Hermansson, N.O., Leonova, J., Elebring, T., Nilsson, K., Drmota, T. & Greasley, P.J. (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol., 152, 10921101.
  • Salio, C., Fischer, J., Franzoni, M.F. & Conrath, M. (2002) Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. Neuroscience, 110, 755764.
  • Savinainen, J.R., Saario, S.M., Niemi, R., Jarvinen, T. & Laitinen, J.T. (2003) An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors. Br. J. Pharmacol., 140, 14511459.
  • Smart, D. & Jerman, J.C. (2000) Anandamide: an endogenous activator of the vanilloid receptor. Trends Pharmacol. Sci., 21, 134.
  • Song, B. & Marvizon, J.C. (2003) Peptidases prevent μ-opioid receptor internalization in dorsal horn neurons by endogenously released opioids. J. Neurosci., 23, 18471858.
  • Starowicz, K., Nigam, S. & Di Marzo, V. (2007) Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther., 114, 1333.
  • Storkson, R.V., Kjorsvik, A., Tjolsen, A. & Hole, K. (1996) Lumbar catheterization of the spinal subarachnoid space in the rat. J. Neurosci. Methods, 65, 167172.
  • Strock, J. & Diverse-Pierluissi, M.A. (2004) Ca2+ channels as integrators of G protein-mediated signaling in neurons. Mol. Pharmacol., 66, 10711076.
  • Trafton, J.A., Abbadie, C., Marchand, S., Mantyh, P.W. & Basbaum, A.I. (1999) Spinal opioid analgesia: how critical is the regulation of substance P signaling? J. Neurosci., 19, 96429653.
  • Traub, R.J. (1996) The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain, 67, 151161.
  • Turu, G., Simon, A., Gyombolai, P., Szidonya, L., Bagdy, G., Lenkei, Z. & Hunyady, L. (2007) The role of diacylglycerol lipase in constitutive and angiotensin AT1 receptor-stimulated cannabinoid CB1 receptor activity. J. Biol. Chem., 282, 77537757.
  • Waldeck-Weiermair, M., Zoratti, C., Osibow, K., Balenga, N., Goessnitzer, E., Waldhoer, M., Malli, R. & Graier, W.F. (2008) Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression. J. Cell Sci., 121, 17041717.
  • Wallace, W., Schaefer, L.H. & Swedlow, J.R. (2001) A workingperson’s guide to deconvolution in light microscopy. BioTechniques, 31, 10761078.
  • Wilson, R.I. & Nicoll, R.A. (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature, 410, 588592.
  • Wilson, R.I. & Nicoll, R.A. (2002) Endocannabinoid signaling in the brain. Science, 296, 678682.
  • Yaksh, T.L. & Rudy, T.A. (1976) Chronic catheterization of the spinal subarachnoid space. Physiol. Behav., 17, 10311036.
  • Yaksh, T.L., Jessell, T.M., Gamse, R., Mudge, A.W. & Leeman, S.E. (1980) Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature, 286, 155157.
  • Zhang, G., Lao, L. & Marvizon, J.C. (2008) Cannabinoid CB1 receptor facilitation of substance P release from primary afferent terminals in the rat spinal cord. Abstr Soc Neurosci., 34, 772.
  • Zimmer, A., Zimmer, A.M., Hohmann, A.G., Herkenham, M. & Bonner, T.I. (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl Acad. Sci. USA, 96, 57805785.
  • Zorman, G., Belcher, G., Adams, J.E. & Fields, H.L. (1982) Lumbar intrathecal naloxone blocks analgesia produced by microstimulation of the ventromedial medulla in the rat. Brain Res., 236, 7784.
  • Zygmunt, P.M., Petersson, J., Andersson, D.A., Chuang, H., Sorgard, M., Di, M.V., Julius, D. & Hogestatt, E.D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452457.